U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Substance Class Protein
Created
by admin
on Sat Dec 16 11:02:57 GMT 2023
Edited
by admin
on Sat Dec 16 11:02:57 GMT 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
QS5F6VTS0O
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PAMREVLUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
PAMREVLUMAB [USAN]
Common Name English
pamrevlumab [INN]
Common Name English
FG-3019
Code English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CTGF (CONNECTIVE TISSUE GROWTH FACTOR, CCN FAMILY MEMBER 2, CCN2, HYPERTROPHIC CHONDROCYTE-SPECIFIC PROTEIN 24, HCS24, INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 8, IGFBP- 8)), HOMO SAPIENS MONOCLONAL ANTIBODY
Systematic Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CONNECTIVE TISSUE GROWTH FACTOR) (HUMAN MONOCLONAL FG-3019 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL FG-3019 .KAPPA.-CHAIN, DIMER
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CTGF (CONNECTIVE TISSUE GROWTH FACTOR, CCN FAMILY MEMBER 2,CCN2, HYPERTROPHIC CHONDROCYTE-SPECIFIC PROTEIN 24, HCS24, INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 8, IGFBP-8)), HOMO SAPIENS MONOCLONAL ANTIBODY
Common Name English
Pamrevlumab [WHO-DD]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 680319
Created by admin on Sat Dec 16 11:02:57 GMT 2023 , Edited by admin on Sat Dec 16 11:02:57 GMT 2023
FDA ORPHAN DRUG 351211
Created by admin on Sat Dec 16 11:02:57 GMT 2023 , Edited by admin on Sat Dec 16 11:02:57 GMT 2023
FDA ORPHAN DRUG 581617
Created by admin on Sat Dec 16 11:02:57 GMT 2023 , Edited by admin on Sat Dec 16 11:02:57 GMT 2023
Code System Code Type Description
DRUG BANK
DB14952
Created by admin on Sat Dec 16 11:02:57 GMT 2023 , Edited by admin on Sat Dec 16 11:02:57 GMT 2023
PRIMARY
INN
10060
Created by admin on Sat Dec 16 11:02:57 GMT 2023 , Edited by admin on Sat Dec 16 11:02:57 GMT 2023
PRIMARY
USAN
DE-89
Created by admin on Sat Dec 16 11:02:57 GMT 2023 , Edited by admin on Sat Dec 16 11:02:57 GMT 2023
PRIMARY
ChEMBL
CHEMBL2109377
Created by admin on Sat Dec 16 11:02:57 GMT 2023 , Edited by admin on Sat Dec 16 11:02:57 GMT 2023
PRIMARY
CAS
946415-13-0
Created by admin on Sat Dec 16 11:02:57 GMT 2023 , Edited by admin on Sat Dec 16 11:02:57 GMT 2023
PRIMARY
NCI_THESAURUS
C92577
Created by admin on Sat Dec 16 11:02:57 GMT 2023 , Edited by admin on Sat Dec 16 11:02:57 GMT 2023
PRIMARY
FDA UNII
QS5F6VTS0O
Created by admin on Sat Dec 16 11:02:57 GMT 2023 , Edited by admin on Sat Dec 16 11:02:57 GMT 2023
PRIMARY
From To
1_22 1_95
1_147 1_203
1_264 1_324
1_370 1_428
2_22 2_95
2_147 2_203
2_264 2_324
2_370 2_428
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
1_223 3_214
2_223 4_214
1_229 2_229
1_232 2_232
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_300
N 2_300
Related Record Type Details
CONNECTIVE TISSUE GROWTH FACTOR
TARGET -> INHIBITOR
Related Record Type Details
PAMREVLUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966